Impact on prognosis of rebiopsy in advanced non-small cell lung cancer patients after epidermal growth factor receptor-tyrosine kinase inhibitor treatment: a systematic review.
Takuma ImakitaHirotaka MatsumotoKatsuya HiranoToshiyuki MorisawaAzusa SakuraiYuki KataokaPublished in: BMC cancer (2019)
Only a few previous studies have investigated the effectiveness of rebiopsy. Hence, further study is needed to determine the prognosis or adverse events of rebiopsy.